Procodazole
Based on 1 Customer Validation
Procodazole is an orally active enhancer and a non-specific active immune protector against viral and bacterial infections. Procodazole also exhibits antiparasitic activity. In addition, Procodazole is a carbonic anhydrase inhibitor with antitumor activity.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit: 99.73%
- CAS. Nr.: 23249-97-0
- Formel: C10H10N2O2
- Molecular Weight:190.20
-
Speicherung:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biologische Aktivität
-
Chemical Information
-
Lösungsmittel & Löslichkeit
- Reinheit & Dokumentation
- Verweise
-
Help & FAQs
-
HY-B1056R
Procodazole (Standard)
-
HY-B0413
Fenbendazole
-
HY-B0223
Albendazole
-
HY-B0413R
Fenbendazole (Standard)
-
HY-B0223R
Albendazole (Standard)
-
HY-10571A
Delavirdine mesylate
-
HY-109654
Ensulizole
-
HY-16726
Polmacoxib
-
HY-B0483
Tioxolone
-
HY-B1386
Halazone
-
HY-W010372
1-Methylbenzimidazole
-
HY-W012445
Telmisartan impurity 12
Alle Parasite Isoform-spezifische Produkte anzeigen
MoreAlle Antibiotic Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
|
CA IX 8.35 μM (IC50) |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| LNCaP | GI50 |
>50 μM
Compound: 8
|
Antiproliferative activity against human LNCAP cells assessed as inhibition of cell growth incubated for 96 hrs by MTT assay
Antiproliferative activity against human LNCAP cells assessed as inhibition of cell growth incubated for 96 hrs by MTT assay
|
[PMID: 28838831] |
| PC-3 | GI50 |
>50 μM
Compound: 8
|
Antiproliferative activity against human PC3 cells assessed as inhibition of cell growth incubated for 96 hrs by MTT assay
Antiproliferative activity against human PC3 cells assessed as inhibition of cell growth incubated for 96 hrs by MTT assay
|
[PMID: 28838831] |
Procodazole (8.35 μM, 90 min) exerts its antitumor activity by inhibiting carbonic anhydrase IX, with an IC50 of 8.35 μM[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Three-month-old Beagle puppies infected with 3000 embryonated Toxocara canis eggs[2]
-
Dosage:50 mg per dog
-
Administration:Oral gavage (p.o.), once daily for 28 days
-
Result:Reduced the number of worms significantly in the treated group compared to the untreated group, with a 63.8% reduction in worm burden.
Chemical Information
-
CAS. Nr. 23249-97-0
-
Appearance Solid
-
Molecular Weight 190.20
-
Formel C10H10N2O2
-
Color White to off-white
-
SMILES
O=C(O)CCC1=NC2=CC=CC=C2N1
-
Synonyms
Propazol; 2-Benzimidazolepropionic acid
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Powder -20°C 3 years 4°C 2 years In solvent -80°C 2 years -20°C 1 year
Lösungsmittel & Löslichkeit
DMSO : 50 mg/mL (262.88 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (13.14 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.5 mg/mL (13.14 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Reinheit & Dokumentation
-
Data Sheet (273 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
Verweise
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 5.2576 mL | 26.2881 mL | 52.5762 mL | 131.4406 mL |
| 5 mM | 1.0515 mL | 5.2576 mL | 10.5152 mL | 26.2881 mL | |
| 10 mM | 0.5258 mL | 2.6288 mL | 5.2576 mL | 13.1441 mL | |
| 15 mM | 0.3505 mL | 1.7525 mL | 3.5051 mL | 8.7627 mL | |
| 20 mM | 0.2629 mL | 1.3144 mL | 2.6288 mL | 6.5720 mL | |
| 25 mM | 0.2103 mL | 1.0515 mL | 2.1030 mL | 5.2576 mL | |
| 30 mM | 0.1753 mL | 0.8763 mL | 1.7525 mL | 4.3814 mL | |
| 40 mM | 0.1314 mL | 0.6572 mL | 1.3144 mL | 3.2860 mL | |
| 50 mM | 0.1052 mL | 0.5258 mL | 1.0515 mL | 2.6288 mL | |
| 60 mM | 0.0876 mL | 0.4381 mL | 0.8763 mL | 2.1907 mL | |
| 80 mM | 0.0657 mL | 0.3286 mL | 0.6572 mL | 1.6430 mL | |
| 100 mM | 0.0526 mL | 0.2629 mL | 0.5258 mL | 1.3144 mL |
Procodazole Related Classifications
HY-B1056 Related Classifications
Powered by Bioz